Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

Fig. 2

Identification of the immunophenotype of WJ-MSCs and AM-MSCs at P3 by flow cytometric analysis. a Representative result from five independent experiments. b Percentage of surface marker expression of WJ-MSCs and AM-MSCs. Mean ± SD of five independent experiments. AM-MSCs amniotic membrane mesenchymal stem cells, WJ-MSCs Wharton’s jelly mesenchymal stem cells

Back to article page